Present and future management of anti-neutrophil cytoplasmic antibody associated vasculitis: how therapy changed the prognosis
Submitted: 5 February 2013
Accepted: 5 February 2013
Published: 4 March 2013
Accepted: 5 February 2013
Abstract Views: 990
PDF: 652
HTML: 977
HTML: 977
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Paola Gnerre, Sandra Buscaglia, Alessandro Cattana, Andrea Pestarino, Silvia Ardoino, Ezio Venturino, Lionello Parodi, Hypocomplementemic urticarial vasculitis complicated with diffuse alveolar hemorrhage: a case report and review of literature , Italian Journal of Medicine: Vol. 8 No. 1 (2014)
- Michele Stornello, Roberto Cappellani, Giuseppe Micieli, Simona Sacco, Stefano Spolveri, Roberto Sterzi, Danilo Toni, Antonio Carolei, Cryptogenic stroke , Italian Journal of Medicine: Vol. 10 No. 3 (2016)
- Balzarini Laura, Chiara Mancini, Mario Uccelli, Enrico Betri, Maurizio Marvisi, Acute pneumonitis or vasculitis? A severe case with multiple organ involvement , Italian Journal of Medicine: Vol. 9 No. 4 (2015)
You may also start an advanced similarity search for this article.